Email Updates

You are here

26 August 2017 VOLUME 17 ISSUE 34

Media Coverage

  • The human body is capable under certain conditions of creating broadly neutralizing HIV-1 antibodies, or bNAbs, to fight the virus.

    August 26, 2016
    Duke Chronicle
  • Researchers at the University of Colorado Skaggs School of Pharmacy have developed a technique that estimates an HIV-negative patient's adherence to drugs prescribed to prevent HIV transmission during sex. The test measures traces of antiretroviral drugs in a spot of dried blood to determine how much pre-exposure prophylactic, or PrEP, medicine a patient has used.

    August 25, 2016
  • The Parliamentary Committee on AIDS said Wednesday that the government has to bear the burden, and ensure the war against HIV/AIDS is won...."The committee has asked the government to inject more money following the withdrawal of or the reduction of assistance from donors; it has no choice but to provide drugs free of charge and allow private sector to import drugs," he said.

    August 25, 2016
  • The first-of-its-kind bill to to boost awareness of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to prevent HIV infection has now reached the desk of California Governor Jerry Brown after receiving strong support in both the Senate and the Assembly.

    August 25, 2016
    Frontiers Media
  • A possible shortcut to an effective HIV vaccine has been discovered....The approach yielded powerful antibodies modeled after those found in rare individuals infected with HIV. These antibodies....don't require the immune system to jump through as many hoops to produce.

    August 25, 2016
    Antibody Related Research
    San Diego Union Tribune
  • WikiLeaks was founded as a giant digital library where leaked documents could be posted in efforts to fight corruption, war and spying. But an increasing number of ordinary citizens are finding that they are collateral damage, as data dumps on WikiLeaks reveal sexual assault victims and people living with HIV and hepatitis and divulge myriad other personal details, The Associated Press reports.

    August 24, 2016
  • The European Commission, which has authority over new drug in the European Union, has approved Truvada for HIV pre-exposure prophylaxis, Gilead Sciences announced this week. While this marketing authorization allows Truvada for PrEP to be sold throughout the EU, regulatory authorities in each country have the final say over whether to approve it and national health systems will decide whether to offer PrEP widely and pay for it.

    August 24, 2016
    HIV & Hepatitis
  • Birth control pills and some types of injectable and implanted contraceptives were not associated with an increased risk of HIV acquisition found a German meta-analysis. However, evidence continues to suggest that use of depot medroxyprogesterone acetate (DMPA or Depo-Provera) raises the likelihood of HIV infection. The WHO plans to meet soon to assess whether guidance needs to change in the light of the new findings.

    August 24, 2016
    Medical Brief
  • Insufficient capacity to perform laboratory tests used in monitoring HIV infection, and underutilization of existing testing capacity, are limiting the ability to meet the Joint United Nations Programme on HIV and AIDS 90-90-90 targets, suggests a new study in PLOS Medicine.

    August 23, 2016
    Science Daily
  • A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

    August 23, 2016
    Science Daily
  • Providing HIV medication to both members of a couple may substantially reduce the risk of transmission within that couple, according to a study in PLOS Medicine....The researchers note that conclusions are limited because this study does not include a concurrent comparison population for HIV transmission....Nevertheless, the findings suggest this may be a promising strategy for in the fight to reverse the HIV epidemic.

    August 23, 2016
    Science Daily
  • Until as recently as 10 years ago, much of what we know about the punani, or slang for vagina, was based on old observations made from a small number of cadaver dissections. But this is changing.

    August 22, 2016
  • When 34-year-old “Frank” was diagnosed with a varicocele,...his doctor told him he needed surgery. The operation would be routine but after he told doctors he was HIV-positive, the procedure was postponed several times....Frank wasn’t surprised....The mainland’s decade-old Aids Prevention and Treatment Regulations are meant to stop hospitals turning away HIV-positive patients but activists say patients continue to face repeated rejection at medical facilities across the country.

    August 20, 2016
    South China Morning Post
  • The New York City Department of Health, led by assistant commissioner of the Bureau of HIV/AIDS Prevention and Control Dr Demetre Daskalakis, has signed a groundbreaking consensus declaring that the risk of HIV transmission could be removed by faithfully following antiretroviral treatments. Dr. Daskalakis is the first major public health official in the United States signing the consensus, also signed by his counterparts in Denmark, Australia and Switzerland.

    August 19, 2016
    Nature World News
  • In a national survey,...only 1 in 5 parents agreed that laws requiring HPV vaccination for school entry are a "good idea." When added to the number of parents who only backed the requirements if opt-out provisions were included, support increased to nearly 60 percent. However, this opt-out provision could make the laws far less effective...and means physicians and other health care providers are key to improving HPV vaccination rates.

    August 19, 2016
    Science Daily
  • The good news is that, as researchers uncover the complexity of those communities, they are also finding ways to strengthen them, crafting new tools that not only could make women less susceptible to HIV but also improve their health overall. And it highlights the vagina as a powerful HIV prevention tool in itself, said Alison Roxby, a researcher at the University of Washington who studies how the injectable contraceptive Depo-Provera impacts HIV acquisition.

    August 19, 2016
    PBS NewsHour
  • When investigators at the German Institute for Quality and Efficiency in Health Care reviewed emtricitabine/tenofovir alafenamide, approved in combination with other antiviral agents for treatment of adults and adolescents infected with HIV-1, they found that partly no data were available and partly the appropriate comparator therapy was not adhered to [and] risk of nervous system disorders was increased for one patient group.

    August 18, 2016
    Science Daily
  • The standard approach to first-line HIV therapy is to combine two NRTIs with a drug from another drug class. ViiV wants to see if it is possible to reduce drug exposure and improve adherence to therapy, while maintaining the same level of efficacy, with a two-drug regimen. Two phase III studies - GEMINI-1 and GEMINI-2 - will enrol approximately 1,400 men and women living with Europe, Central and South America, North America, South Africa and Asia Pacific.

    August 17, 2016
    PM Live

Published Research